Differential effects of plant and animal fats on obesity‐induced dyslipidemia and atherosclerosis in Ldlr−/−.Leiden mice
暂无分享,去创建一个
[1] Rudina Ndreu,et al. Classes of Lipid Mediators and Their Effects on Vascular Inflammation in Atherosclerosis , 2023, International journal of molecular sciences.
[2] R. Kleemann,et al. Lipid profiling analyses from mouse models and human infants , 2022, STAR protocols.
[3] F. Baas,et al. Therapeutic Intervention with Anti-Complement Component 5 Antibody Does Not Reduce NASH but Does Attenuate Atherosclerosis and MIF Concentrations in Ldlr-/-.Leiden Mice , 2022, International journal of molecular sciences.
[4] R. Kleemann,et al. Intervention with isoleucine or valine corrects hyperinsulinemia and reduces intrahepatic diacylglycerols, liver steatosis, and inflammation in Ldlr−/−.Leiden mice with manifest obesity‐associated NASH , 2022, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] M. Giera,et al. The Human Milk Oligosaccharide 2′-Fucosyllactose Alleviates Liver Steatosis, ER Stress and Insulin Resistance by Reducing Hepatic Diacylglycerols and Improved Gut Permeability in Obese Ldlr-/-.Leiden Mice , 2022, Frontiers in Nutrition.
[6] C. Serhan,et al. Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions , 2022, Progress in lipid research.
[7] Steffen E. Petersen,et al. European Society of Cardiology: cardiovascular disease statistics 2021. , 2022, European heart journal. Quality of care & clinical outcomes.
[8] P. Libby. Inflammation during the life cycle of the atherosclerotic plaque. , 2021, Cardiovascular research.
[9] A. B. Storsve,et al. Krill Oil Treatment Increases Distinct PUFAs and Oxylipins in Adipose Tissue and Liver and Attenuates Obesity-Associated Inflammation via Direct and Indirect Mechanisms , 2021, Nutrients.
[10] J. Sowers,et al. Obesity, Adipose Tissue and Vascular Dysfunction. , 2021, Circulation research.
[11] R. Kleemann,et al. Cholesterol Accumulation as a Driver of Hepatic Inflammation Under Translational Dietary Conditions Can Be Attenuated by a Multicomponent Medicine , 2021, Frontiers in Endocrinology.
[12] R. Kleemann,et al. A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology , 2020, Cells.
[13] P. Libby,et al. Atherosclerosis , 2019, Nature Reviews Disease Primers.
[14] R. Kleemann,et al. Sex-Specific Differences in Fat Storage, Development of Non-Alcoholic Fatty Liver Disease and Brain Structure in Juvenile HFD-Induced Obese Ldlr-/-.Leiden Mice , 2019, Nutrients.
[15] Ira Tabas,et al. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities , 2019, Nature Reviews Cardiology.
[16] P. Ridker,et al. Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease , 2019, Front. Cardiovasc. Med..
[17] M. Blüher. Obesity: global epidemiology and pathogenesis , 2019, Nature Reviews Endocrinology.
[18] R. Kleemann,et al. Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr‐/‐.Leiden Mice , 2018, Hepatology communications.
[19] J. Speakman,et al. Dietary Fat, but Not Protein or Carbohydrate, Regulates Energy Intake and Causes Adiposity in Mice. , 2018, Cell metabolism.
[20] R. Kleemann,et al. Extra‐Virgin Olive Oil with Natural Phenolic Content Exerts an Anti‐Inflammatory Effect in Adipose Tissue and Attenuates the Severity of Atherosclerotic Lesions in Ldlr−/−.Leiden Mice , 2018, Molecular nutrition & food research.
[21] Paul Timpson,et al. Evidence that TLR4 Is Not a Receptor for Saturated Fatty Acids but Mediates Lipid-Induced Inflammation by Reprogramming Macrophage Metabolism. , 2018, Cell metabolism.
[22] F. Hu,et al. Diet and Cardiovascular Disease: Advances and Challenges in Population-Based Studies. , 2018, Cell metabolism.
[23] F. Hu,et al. Dietary Fat and Risk of Cardiovascular Disease: Recent Controversies and Advances. , 2017, Annual review of nutrition.
[24] Michael Miller,et al. Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association , 2017, Circulation.
[25] S. Fazio,et al. Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease , 2017, F1000Research.
[26] J. Olefsky,et al. Inflammatory mechanisms linking obesity and metabolic disease , 2017, The Journal of clinical investigation.
[27] T. Kooistra,et al. Resolvin E1 attenuates atherosclerosis in absence of cholesterol-lowering effects and on top of atorvastatin. , 2016, Atherosclerosis.
[28] K. Walsh,et al. Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease. , 2016, Circulation research.
[29] R. Krauss,et al. Vaccenic acid and trans fatty acid isomers from partially hydrogenated oil both adversely affect LDL cholesterol: a double-blind, randomized controlled trial. , 2015, The American journal of clinical nutrition.
[30] Dan J Stein,et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, BDJ.
[31] T. Kooistra,et al. Replacement of Dietary Saturated Fat by PUFA-Rich Pumpkin Seed Oil Attenuates Non-Alcoholic Fatty Liver Disease and Atherosclerosis Development, with Additional Health Effects of Virgin over Refined Oil , 2015, PloS one.
[32] H. Aukema,et al. Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs. , 2015, Advances in nutrition.
[33] L. Ferder,et al. Inflammation, oxidative stress and renin angiotensin system in atherosclerosis. , 2015, World journal of biological chemistry.
[34] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[35] R. Andrews,et al. Targeting GPVI as a novel antithrombotic strategy , 2014, Journal of blood medicine.
[36] Kazuto Nakamura,et al. Adipokines: a link between obesity and cardiovascular disease. , 2014, Journal of cardiology.
[37] Andreas Krämer,et al. Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..
[38] F. Milagro,et al. Adiposoft: automated software for the analysis of white adipose tissue cellularity in histological sections , 2012, Journal of Lipid Research.
[39] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[40] Johannes E. Schindelin,et al. Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.
[41] T. Osborne,et al. Liver x receptors in atherosclerosis and inflammation. , 2011, Circulation research.
[42] J. H. van Bockel,et al. MIF Deficiency Reduces Chronic Inflammation in White Adipose Tissue and Impairs the Development of Insulin Resistance, Glucose Intolerance, and Associated Atherosclerotic Disease , 2009, Circulation research.
[43] J. German,et al. Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. , 2008, The American journal of clinical nutrition.
[44] A. Fukamizu,et al. Requirement of apelin-apelin receptor system for oxidative stress-linked atherosclerosis. , 2007, The American journal of pathology.
[45] J. Borén,et al. Ira Tabas , Kevin Jon Williams and Jan Borén and Therapeutic Implications Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis : Update , 2007 .
[46] T. Kooistra,et al. Mouse models for atherosclerosis and pharmaceutical modifiers. , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[47] D. Rader,et al. Obesity and atherogenic dyslipidemia. , 2007, Gastroenterology.
[48] J. Bernhagen,et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment , 2007, Nature Medicine.
[49] Shupei Wang,et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans Published, JLR Papers in Press, September 8, 2005. DOI 10.1194/jlr.M500294-JLR200 , 2005, Journal of Lipid Research.
[50] C. Meisinger,et al. Plasma Oxidized Low-Density Lipoprotein, a Strong Predictor for Acute Coronary Heart Disease Events in Apparently Healthy, Middle-Aged Men From the General Population , 2005, Circulation.
[51] A. Chait,et al. Nutrition and inflammation: role of dietary cholesterol , 2004 .
[52] R. van Haperen,et al. Increased Fecal Bile Acid Excretion in Transgenic Mice With Elevated Expression of Human Phospholipid Transfer Protein , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[53] Dallas Jones,et al. Emerging roles of PPARS in inflammation and immunity , 2002, Nature Reviews Immunology.
[54] B. Staels,et al. The role of PPARs in atherosclerosis. , 2002, Trends in molecular medicine.
[55] J. Bernhagen,et al. Expression of Macrophage Migration Inhibitory Factor in Different Stages of Human Atherosclerosis , 2002, Circulation.
[56] J. Dietschy. Dietary fatty acids and the regulation of plasma low density lipoprotein cholesterol concentrations. , 1998, The Journal of nutrition.
[57] W D Wagner,et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[58] W D Wagner,et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[59] V. Schumaker,et al. Plasma very low density lipoproteins contain a single molecule of apolipoprotein B. , 1988, Journal of lipid research.
[60] R. Kleemann,et al. Role of Macrophage Migration Inhibitory Factor in Obesity, Insulin Resistance, Type 2 Diabetes, and Associated Hepatic Co-Morbidities: A Comprehensive Review of Human and Rodent Studies , 2015, Front. Immunol..
[61] Jana Kalz,et al. Thrombin generation and atherosclerosis , 2013, Journal of Thrombosis and Thrombolysis.
[62] D. Harrison,et al. Mouse models in aging research. , 2007 .
[63] H. CStary,et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1994 .